M&A Deal Summary

Inovio Pharmaceuticals Acquires VGX Pharmaceuticals

On June 2, 2009, Inovio Pharmaceuticals acquired healthcare services company VGX Pharmaceuticals for 45M TRY

Acquisition Highlights
  • This is Inovio Pharmaceuticals’ 1st transaction in the Healthcare Services sector.
  • This is Inovio Pharmaceuticals’ 0th largest (disclosed) transaction.
  • This is Inovio Pharmaceuticals’ 1st transaction in the United States.
  • This is Inovio Pharmaceuticals’ 1st transaction in Pennsylvania.

M&A Deal Summary
Date 2009-06-02
Target VGX Pharmaceuticals
Sector Healthcare Services
Buyer(s) Inovio Pharmaceuticals
Deal Type Add-on Acquisition
Deal Value 45M TRY

Target

VGX Pharmaceuticals

Blue Bell, Pennsylvania, United States
VGX Pharmaceuticals is engaged in the discovery and development of novel vaccines and therapies for major infectious diseases and cancers.

Search 198,242 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Inovio Pharmaceuticals

Plymouth Meeting, Pennsylvania, United States
Category Company
Founded 1979
Sector Medical Products
Employees122
Revenue 10M USD (2022)
DESCRIPTION

Inovio Pharmaceuticals is a bio pharmaceutical company discovers, develops, and develops synthetic vaccines and immune therapies focusing on cancers and infectious diseases. Inovio Pharmaceuticals was founded in 1979 and is based in Plymouth Meeting, Pennsylvania.

DEAL STATS #
Overall 1 of 2
Sector (Healthcare Services) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Pennsylvania) 1 of 1
Country (United States) 1 of 2
Year (2009) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-03-14 Bioject Medical Technologies - Needle-Free Injection Technology

United States

Bioject Medical Technologies - Needle-Free Injection Technology includes pioneering needle-free jet injection technology, devices, and intellectual property.

Buy $6M
Mergr

Product

Company

Legal